Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

256 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treatment of recurrent high-grade gliomas.
Wen PY, Brandes AA. Wen PY, et al. Among authors: brandes aa. Curr Opin Neurol. 2009 Dec;22(6):657-64. doi: 10.1097/WCO.0b013e32833229e3. Curr Opin Neurol. 2009. PMID: 19770658 Review.
Appropriate end-points for right results in the age of antiangiogenic agents: future options for phase II trials in patients with recurrent glioblastoma.
Brandes AA, Franceschi E, Gorlia T, Wick W, Jacobs AH, Baumert BG, van den Bent M, Weller M, Stupp R; European Organisation for Research and Treatment of Cancer Brain Tumour Group. Brandes AA, et al. Eur J Cancer. 2012 Apr;48(6):896-903. doi: 10.1016/j.ejca.2011.10.027. Epub 2011 Nov 24. Eur J Cancer. 2012. PMID: 22119352 Review.
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
Franceschi E, Cavallo G, Lonardi S, Magrini E, Tosoni A, Grosso D, Scopece L, Blatt V, Urbini B, Pession A, Tallini G, Crinò L, Brandes AA. Franceschi E, et al. Among authors: brandes aa. Br J Cancer. 2007 Apr 10;96(7):1047-51. doi: 10.1038/sj.bjc.6603669. Epub 2007 Mar 13. Br J Cancer. 2007. PMID: 17353924 Free PMC article. Clinical Trial.
Is protracted low-dose temozolomide feasible in glioma patients?
Tosoni A, Cavallo G, Ermani M, Scopece L, Franceschi E, Ghimenton C, Gardiman M, Pasetto L, Blatt V, Brandes AA. Tosoni A, et al. Among authors: brandes aa. Neurology. 2006 Feb 14;66(3):427-9. doi: 10.1212/ Neurology. 2006. PMID: 16476947
Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971.
van den Bent MJ, Taphoorn MJ, Brandes AA, Menten J, Stupp R, Frenay M, Chinot O, Kros JM, van der Rijt CC, Vecht ChJ, Allgeier A, Gorlia T; European Organization for Research and Treatment of Cancer Brain Tumor Group. van den Bent MJ, et al. Among authors: brandes aa. J Clin Oncol. 2003 Jul 1;21(13):2525-8. doi: 10.1200/JCO.2003.12.015. J Clin Oncol. 2003. PMID: 12829671 Clinical Trial.
Temozolomide chemotherapy in recurrent oligodendroglioma.
van den Bent MJ, Keime-Guibert F, Brandes AA, Taphoorn MJ, Kros JM, Eskens FA, Carpentier AF. van den Bent MJ, et al. Among authors: brandes aa. Neurology. 2001 Jul 24;57(2):340-2. doi: 10.1212/wnl.57.2.340. Neurology. 2001. PMID: 11468326
New drugs in recurrent high grade gliomas.
Brandes AA, Pasetto LM, Monfardini S. Brandes AA, et al. Anticancer Res. 2000 May-Jun;20(3B):1913-20. Anticancer Res. 2000. PMID: 10928126 Review.
256 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page